A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Mesonephric Gynecologic Cancer

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
Contact: Study coordinator (Rachel Grisham, MD) · 646-888-4653
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
Contact: Study coordinator (Rachel Grisham, MD) · 646-888-4653
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
Contact: Study coordinator (Rachel Grisham, MD) · 646-888-4653
Memorial Sloan Kettering Suffolk -Commack (Limited Protocol Activities), Commack, New York, United States
Contact: Study coordinator (Rachel Grisham, MD) · 646-888-4653
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
Contact: Study coordinator (Rachel Grisham, MD) · 646-888-4653
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Rachel Grisham, MD) · 646-888-4653
Contact: Study coordinator (Carol Aghajanian, MD) · 646-888-4217
Contact: Principal Investigator (Rachel Grisham, MD)
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States
Contact: Study coordinator (Rachel Grisham, MD) · 646-888-4653

מובילי המחקר

Rachel Grisham, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center